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The  exact  nature  of  the  ultrastructural  membrane  lesions  (1)  caused  by  the 
membrane attack complex (C5b-9)  (2-4) of complement has been unknown. Visual- 
ized by the negative staining technique, the lesions exhibit a dark central area which 
is surrounded by a ring having an external diameter of approximately 200/~ (5). The 
occurrence of the lesions is dependent upon the presence on the target membrane of 
all five proteins of the membrane attack complex: C5b, C6, C7, C8, and C9  (6-8). 
Ferritin-labeled  antibodies  to (25  and C8  (M. J.  Policy,  unpublished  observations) 
and  to  C9  (9),  applied  to  complement  lysed  cells,  were  found  to  localize  in  the 
immediate vicinity of the complement produced lesions. These observations suggested 
that  the proteins of the C5b-9 complex have a  close topological relationship to the 
ultrastructural lesions. 
It  has  previously  been  shown  that  membrane  bound  C5b-9  has  a  fluid  phase 
equivalent. It is formed upon complement activation in serum (3, 4) and contains an 
additional protein, called S-protein, which is an inhibitor of forming C5b-9 (10). The 
SC5b-9 complex was found to have a  mol wt of 1.04  ×  106 daltons and, as will be 
shown  below, an ultrastructure  that  is apparently unrelated  to the structure of the 
membrane lesions. In contrast, the C5b-9 complex extracted from complement lysed 
cells was reported  to have the  ultrastructure  of a  hollow cylinder and the electron 
microscopic appearance of complement produced membrane lesions (11). 
We wish to report that the membrane attack complex extracted from complement 
lysed cells by deoxycholate constitutes the dimer of C5b-9 and that it is the dimeric 
form of the complex that, by itself or incorporated into lipid bilayers, evokes the ring 
shaped image of the typical complement lesions. The term membrane attack complex, 
(MAC), x will therefore be applied only to the complex having the structural formula 
(C5b-9) 2. 
Materials and Methods 
Isolated Proteins.  (25b-6 (12), (26 and C 7 (13), (28 (14) and S(25b-9 (4) were purified according 
to published  methods.  C9 was purified according to the  method of Biesecker and  Miiller- 
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Eberhard.  2 Proteins  were radiolabclcd  with iodine by the chloraminc T  method (15)  and 
radioactivity  measured using a Packard auto-gamma scintillation  counter. 
Serum and E~ythrocytes. Rabbit erythrocytcs  were prepared from fresh  rabbit  blood drawn 
into  ethylenediamine tetra-acetic  acid (EDTA) (final  concentration 0.01  M). The cells  were 
pelleted by ccntrifugation  for 10 rain at 2,000 rpm  (1100 g, International  model PR-2, 
International  Equipment Co.,  Necdham Hts.,  Mass.),  washed four  times  with veronal-buffcred 
saline containing 5 mM  EDTA,  then washed three  times  and resuspendcd with veronal- 
buffered  saline  containing I% (wt/vol)  gelatin  plus  0.5 mM  MgCI2 and 0.15  mM  CaCls. 
Freshly  drawn human blood was allowed to  clot  for  2 h at 37°C and 2 h at 0°C. The clot 
was removed by ccntrifugation  for 20 rain  at 2,000 rpm. After  the addition of I~I-C9 (50 
ng/ml) the  serum was  centrifuged  for  30  min at 12,000  rpm (Sorvall,  HB4 rotor)  to  remove any 
aggregated C9. 
Formation  and  Purification  o/MAC.  Serum was mixed with  rabbit  erythrocytcs  at  a concentra- 
tion  of  2.5  to  5 ×  108  cells/ml  of  serum either  by  suspending packed cells  or mixing the  serum 
I:I with cells  suspended in vcronal-buffcrcd  saline  containing gelatin  plus calcium and 
magnesium. The cells  were lysed  by incubation at 37°C for  20 rnin.  The cell  membranes were 
pelleted  by centrifugation  at 12,000  rpm for  30 rain  (Sorvall,  HB4 rotor,  Sorvall-Du Pont Co., 
Biomedical Div.,  Newtown, Conn.) and washed twice  with 5 mM  EDTA, pH 8.0,  4°C. To the 
packed  white  membranes was  added 15%  deoxycholate (DOC) (Sigma  Chemical Co.,  St.  Louis, 
Mo.), 50 mM  Tris-acetate,  pH 8.9,  to  a final  DOC  concentration  of 10% and the  complex was 
extracted  for  2 h at  room temperature.  The  extract  was  then  centrifuged  at  40,000  rpm (100,000 
g) for I h (Beckman L5-65, SW 50.  I  rotor,  Beckman Instruments,  Inc.,  Fullerton,  Calif.).  The 
detergent  extracted  MAC  was purified  by gel  filtration  in  the presence  of  2% DOC  on BioGel 
A15m.  The complex containing fractions  wcrc pooled on the basis  of radioactivity  and 
concentrated by  Amicon ultrafiltration,  Amicon Corp.,  Lcxington,  Mass.,  (PM 30 membrane). 
The protein  sample was then dialyzed  against  2% DOC, 50 mM  Tris-acetate,  pH 8.6.  Rabbit 
cells  were also  lysed  with guinea pig serum containing 125I-C9  (human) and the guinea pig- 
MAC  extracted  as  described  above for  human MAC. Human MAC  was extracted  from sheep 
crythrocyte  membranes prepared similarly  to  the rabbit  membranes. 
Sodium Dodecyl Sulfate (SDS) Polyacrylamide Gel Electrophoresis was performed according to the 
method of Weber and Osborn (16).  Because high concentrations of DOC interfere with SDS 
binding to proteins, the samples were dialyzed ovcrnight at 37°C against 2% SDS, 6 M  urea 
before clectrophoresis. Phosphate analysis was performed according to thc method of Bartlett 
(17). 
Sucrose Density Gradient Ultrocentrifugation.  Samples were centrifuged on 5-ml linear gradients 
of 10-50% (wt/vol) sucrose, dissolved with 50 mM Tris-acetate, pH 8.6. Some of the gradients 
also contained  1% DOC. Centrifugation was carried out in a Beckman L5-65 ultracentrifuge 
(SW 50.1 rotor) and fractions were collected from the bottom via a needle punched through the 
tube  or  from  the  top  using  an  Auto  Densi-flow  IIC  (Buchler  Instruments  Div.,  Searle 
Diagnostics, Inc., Fort Lee, N. J.). 
Electron Microscopy.  Negatively stained samples were deposited onto parlodion and carbon 
coated 400-mesh copper grids made hydrophilic by placing a drop of 0.01%  (wt/vol) bacitracin 
on each and drawing offexcess fluid with filter paper. 5 #1 of the protein sample (approximately 
0.1  mg/ml) was applied and after 10-30 s, excess sample was removed. 5 #l of 2% phospho- 
tungstic acid, pH 7.0, or uranyl oxalate, pH 6.8 (18),  in distilled water was added. The stain 
was drawn off immediately in the ease of phosphotungstic acid, and after 30 s with uranyl 
oxalate, and the grid was allowed to air dry. Grids were examined in a Hitachi 12A electron 
microscope operated at  75 kV and a  direct magnification of 100,000,  with a  500-#m second 
condenser aperture and a  20-#m objective aperture. The bright-field image was recorded on 
Kodak 4463 electron image film. 
Formation O/MAC with Purified Proteins.  The C5b-9 complex was also formed from purified 
components by reactive lysis (19).  Purified C5b-6,  C8  and  C9 were added to mixed DOC- 
phospholipid micclles and incubated for 10 min at 37°C. Then, C7 was added and the mixture 
incubated for a  further 30 min to form the C5b-9 complex. The complex was extracted with 
10% DOC and analyzed on sucrose density gradient ultracentrifugation. 
Reincorporation o/MAC into Phospholipid Liposomes.  The MAC was reincorporated into phos- 
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FIG.  1.  Purification of MAC extracted from complement lysed cells by molecular sieve chroma- 
tography. MAC membrane complexes were formed by treating 8  X  1011 rabbit erythrocytes with 
850  ml human serum containing tzsI-C9. The MAC was extracted with 60 ml  10%  DOC.  After 
centrifugation, 30 ml was applied to a  5 x  85 cm BioGel AlSm column and  15-ml fractions were 
collected. The flow rate was 20 ml/h. The bar indicates the fractions pooled. 
pholipid liposomes formed by the method of Brunner et al. (20). 1 mg of dried egg lecithin was 
dissolved in 100 p,l 30 mM DO(2, 0.9 M NaCl, 20 mM Tris-acetate, pH 8.6. 200 #1 of MAC (0.4 
mg/ml; 2% IX)C) was added and the sample was gel filtered  at  1 ml/h on Sephadex G50 at 
4°C  (1.5  ×  20 cm;  0.9  M  NaC1, 20  mM Tris-acetate, pH 8.6) to remove the  DOC.  The 
liposomes eluting in the void volume were examined by electron microscopy. 
Results 
Characterization  of the Membrane Attack  Complex  as a  C5b-9 Dimer.  MAC  formation 
was  induced  on  the  surface  of  unsensitized  rabbit  erythrocytes.  This  procedure 
produced four to five times the amount of MAC than formation of MAC on antibody- 
coated sheep  erythrocytes.  A  1%  solution  of the  anionic  detergent  DOC  extracted 
50%, and a  10% solution 90% of the MAC from complement lysed rabbit erythrocytes. 
The MAC could not be eluted from the membranes at high or low salt concentration, 
high pH, or by 0.2 M EDTA, treatments which suffice to remove peripheral membrane 
proteins (21). The nonionic detergents Triton X-100 and Tween 80 at a concentration 
of 1% were ineffective in extracting MAC (19). 
The complex was separated from other proteins by gel filtration on BioGel A15m 
(Fig.  1).  It  eluted  as  a  single  symmetrical,  although  broad  peak  in  the  included 
volume of the column when gel filtration was performed in 2% DOC. Lowering the 
DOC concentration,  although not below the critical micelle concentration, resulted 
in  aggregation of some of the MAC,  which  then eluted  in  the void column.  MAC 
subjected  to  molecular sieve chromatography in  1%  Triton  X-100  was completely 
aggregated. 
Analysis of the purified, unreduced  MAC by SDS polyacrylamide gel electropho- 
resis allowed identification of its subunits as (25b, C6, C7, (28ct-,/, C9, and (28fl (Fig. 
2).  Except for absence of the S-protein, the pattern was qualitatively and quantita- 
tively identical to that of SC5b-9, including  the molar ratios of the subcomponents 
relative to (27  (4,  22).  Fig. 3 shows the sedimentation behavior of the purified MAC 
and of SC5b-9 upon  10-50% sucrose density gradient  ultracentrifugation.  The sedi- 
mentation coefficient of the MAC was 33.5  S compared to 23 S for S(25b-9 (3).  Fig. 
4 shows the purified MAC and S(25b-9 upon gel filtration through Sepharose 4B. The 
diffusion coefficient of the MAC was found to be 1.79  ×  10  -7 compared to  1.98  × 
10  -7 cm2/s for S(25b-9  (3).  On  the  basis of the s-  and  D-values, the mol wt of the BIESECKER, PODACK, HALVERSON, AND MULLER-EBERHARD  451 
FIo. 2.  Subunit  composition  of MAC compared to that of SC5b-9. The complexes  were subjected 
to SDS polyacrylamide gel electrophoresis in unreduced form. The analyses were performed on 
different days under slightly different conditions. The protein bands were identified as indicated. 
Except for the S-protein which is absent from the MAC, the subunit compositions  of  both complexes 
are identical. Degradation of C5b to C5c is more extensive in the MAC than in SC5b-9. 
MAC was calculated to be  1.7  ×  106 daltons and that of SC5b-9  1.0  ×  106 daltons, 
assuming a  partial specific volume (~,) of 0.73 ml/g for both complexes (Table I). No 
phospholipid was detected in the purified MAC by phosphate analysis. 
Human  MAC extracted from sheep erythrocytes and  guinea pig MAC extracted 
from rabbit  erythrocyte membranes also  had  sedimentation  coefficients  of 33.5  S, 
indicating that the size of the MAC is independent of the complement source and the 
species of the target membrane used.  The 33.5  S  MAC was also obtained when the 
complex was  assembled  using  the  purified  components C5b-6,  C7,  C8,  and  C9  in 
presence of mixed phospholipid-DOC micelles and then extracted from the micelles 
with excess DOC. 
By investigating the effect of detergent binding on the size of the extracted complex, 
it was found that the observed difference in size between the MAC and SC5b-9 was 
not a  result of DOC binding. The purified MAC was added to serum and DOC was 
removed by dialysis. The serum treated, detergent-free MAC sedimented upon sucrose 
density gradient  ultracentrifugation  as a  nonaggregated 33.5 S component. Analysis 
of the  complex  by  Ouchterlony  test  and  SDS  polyacrylamide  gel  electrophoresis 
showed the complex to contain,  in addition  to C5b to C9, also the S-protein. Thus, 
during  dialysis DOC  was replaced  by S-protein.  The  fact  that  the  S-protein-MAC 
complex had  an s-rate of 33.5  S  instead of 23  S  shows that  DOC  binding was not 
responsible for the large size of the DOC extracted MAC. It also shows that the MAC 
was not dissociated to the C5b-9 monomer by binding of the S-protein. Neither was 
the  MAC  dissociated  by  reduction  (10  mM  dithiothreitol  for  1  h  at  37°C)  or 452  MEMBRANE  ATTACK  COMPLEX  OF  COMPLEMENT 
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FIG.  3.  Determination  of sedimentation  coefficient  of MAC  by  ultracentrifugation  in  10-50% 
125  sucrose density gradients. The buffer contained  1% DOC.  I-MAC sedimented with s  ,=  33.5  S  x81 
and  I-SC5b-9 with s  =  23 S. The latter had a  faster sedimenting shoulder which was not seen 
when SC5b-9 was analyzed in absence of MAC. The lighter xslI-labeled  material represents some 
dissociated S-protein. 
proteolysis with trypsin (100/~g/ml,  1 h at room temperature). 
The 33.5 S MAC was dissociated to the 23S C5b-9 monomer by incubation in 2% 
DO12, 0.1% SDS for 1 h at room temperature. Although SDS alone is denaturing, the 
mixed  DOC-SDS  micelles  were  not,  as  evidenced  by  the  fact  that  none  of the 
radiolabeled 129 was dissociated from the complex. 
Identification of the Complement Membrane Lesion as c5b-9 Dimer.  Electron microscopic 
examination  of  the  extracted  MAC  yielded  images  that  are  identical  with  the 
appearance of the characteristic membrane lesions (1, 5) caused by complement (Fig. 
5). The ring-like image has an external diameter of 200/~. The other image, which 
may represent a side view, consists of two adjacent, elongated wedges with their long 
axis  measuring  240  ,/k when  stained  with  uranyl  oxalate.  In  contrast,  the  SC5b-9 
complex appears as a single wedge with its long axis measuring 320 ,~ (Fig. 6). Fig. 7 
shows  that  the  extracted  MAC  was  capable  of reineorporation into  phospholipid 
bilayer liposomes.  The  MAC  was  mixed with  egg lecithin-DO12  micelles  and  the 
DOC was separated  from the lipid vesicles by gel filtration. Various aspects of the 
reincorporated MAC are seen which appear as typical complement-dependent mem- 
brane lesions. 
Discussion 
The present study has shown that  (a) the MAC extracted from complement lysed 
cells constitutes the dimer ofC5b-9, (b) the typical complement-dependent membrane BIESECKER, PODACK, HALVERSON, AND MULLER-EBERHARD 
70 
6O- 
5O- 
40 
24" 
"~  lil- 
,D 
6 
k6 
imlin 
~$,C51i-9 
~,~,MAC 
10"5/D 
S'0  so  7"o  so 
Fractioa 
.2O 
o 
x 
ii  ,1O 
qiD 
F1o. 4.  Determination of diffusion coefficient  of MAC by molecular sieve chromatography. A 0.5- 
ml sample of I~I-MAC and mI-SC5b-9 was applied to a  1.6 x 67 cm column of Sepharose 4B 
equilibrated with  1% DOG, 50 mM Tris-acetate, pH 8.6. The flow rate was 5 ml/h and 1-ml 
fractions were collected. 
453 
TABLE  I 
Physical Properties of MAC and SC5b-9 
mol wt (Calcu- mol wt (Calculated 
D  s  f/fo  lated from s and  from composition)  13) 
"MAC  1.79 X  10  -7  33.5 ×  10  -la  1.5  1.7 ×  106  1.6 ×  106* 
SC5b-9  1.98 X 10  -7  23 ×  10  -t3  1.5  1.0 ×  106  1.1  ×  106~ 
D, diffusion coefficient;  s, sedimentation coefficient; f/fo, frictional ratio. 
* Based on dimer of one C5b, C6, C7, C8, and three C9. 
:l: Based on one C5b, C6, C7, C8, three C9, and three S. 
lesion is identical with this dimer and  (c)  the isolated MAC can be reincorporated 
into phospholipid bilayers. 
It  was  previously  proposed  that  the  cytolytic  MAC  is  the  membrane  bound 
analogue of the fluid phase SC5b-9 complex (3).  SC5b-9 has a  mol wt of 1,040,000 
daltons (3) and the C5b-9 portion, which was thought to correspond to the MAC, has 
a  mol  wt  of  800,000  daltons.  In  contrast,  the  MAC  extracted  with  DOC  from 
complement lysed cells was approximately twice as large:  1.7 million daltons. Because 
the subunit composition of the extracted MAC was identical to that of SC5b-9 except 
for  lack  of the  S-protein,  we  concluded  that  the  MAC  represents  (C5b-9)2.  The 
possibility was considered that the dimer was produced during extraction with DOC. 
It  was  ruled  out,  however,  by  the  observation  that  the  dimer  has  the  typical 
ultrastructural appearance of a  complement produced  membrane lesion, while the 
ultrastructure of the  SC5b-9 complex bears no apparent relationship to  the lesion. 
Furthermore, when the isolated dimer was mixed with DOC-phospholipid micelles 454  MEMBRANE  ATTACK COMPLEX OF COMPLEMENT 
Fro.  5.  Ultrastructural  analysis of the MAC. Electron micrographs of the isolated MAC stained 
with phosphotungstic acid (left) at 250,000:1 (upper) and 500,000:1 (lower) and stained with uranyl 
oxalate at 500,000:1 (right). Visualized are ring-like structures closely resembling those seen on 
complement lysed cells. In addition, side views are seen which appear as two adjacent wedges. 
and DOC was subsequently removed, the resultant  phospholipid liposomes exhibited 
characteristic complement lesions on their surface. 
It  is  proposed  therefore  that  the  structural  formula  of  the  MAC  of  human 
complement  is  (C5b,  C6,  C7,  C8,  C98)2.  Dimerization  permits  structural  symmetry 
within  the complex and this  may be an essential  prerequisite  for attaining the ring- 
like  morphology  visualized  upon  examination  of the  isolated  MAC.  Whether  the 
MAC has the geometry of a  hollow cylinder, as has been proposed by others  (11), or 
a  different  geometry remains to be elaborated in the future. 
That  the  appearance  of the  typical  membrane  lesions  depends  on  C9  has  been 
established  (7, 8, 23). Taken together with the present identification of lesions as C5b- 
9 dimers, these observations suggest that dimer formation is induced by binding of C9 
to C5b-8. If dimer formation occurs at the C9 stage of MAC assembly, then the C5b- 
9 monomers should have a certain degree of freedom for lateral movement within the 
target membrane.  Freedom of movement is likely because the forming MAC acts on 
the  lipid  compartment  of  membranes  and  the  lesions  tend  to  occur  in  clusters. 
Whether dimerization  can occur at an earlier  stage of MAC assembly is not known, BIESECKER, PODACK, HALVERSON, AND MULLER-EBERHARD  455 
FIo.  6.  Ultrastructural analysis of the SC5b-9 complex. Electron micrographs of isolated SC5b-9 
stained  with  uranyl oxalate  at  250,000:1  (upper  left),  500,000:1  .(upper  right)  and  1,000,000:1 
(bottom). The complex appears as a wedge-shaped structure of 320 A length and a width at the two 
ends of 200/~ and 80 ,~, respectively. Flexibility of the complex is suggested by the occurrence of 
curved structures. Oligomers are seen in the upper left panel. 
since DOC extracted C5b-7  and C5b-8  complexes  invariably form large aggregates. 
It should be emphasized that functional membrane lesions are already generated at 
the C5b-8  stage of MAC assembly (24, 25)  when ultrastructural lesions are not yet 
detectable. However, the rate of cytolysis is greatly enhanced with attachment of C9 
and C5b-9  dimer formation. The two-step  development of cytolytic activity may be 
related to the increasing phospholipid binding capacity of the forming MAC. It was 
found recently in  this laboratory that C5b-7,  C5b-8  and  (C5b-9)2 are capable of 
binding respectively 400, 800, and  1,400 mol of phospholipid per mole of complex 
(26). The degree of molecular reorganization of membrane lipids effeeted by these 
complexes  may determine the extent of membrane impairment:  the C5b-9  dimer 
causes  extensive transmembrane flux of small ions  and water, the C5b-8  complex 
allows minimal transmembrane flux and the C5b-7 complex is unable to cause such 
a membrane leak. 
Summary 
The membrane attack complex  (MAC)  of complement was  extracted from the 
membranes of cells lysed by human complement and its properties were compared 456  MEMBRANE ATTACK COMPLEX OF COMPLEMENT 
Fla.  7.  Reincorporation  of the isolated MAC into phospholipid liposomes. The preparation was 
stained with uranyl formate and is shown at 500,000:1. The incorporated MAC, of which various 
aspects can be seen, appears identical to the complement produced membrane lesions. All MAC 
particles visualized in this preparation were incorporated into the lipid bilayers. 
with  those of the  fluid phase complex SC5b-9.  Upon sodium dodecyl sulfate poly- 
acrylamide gel electrophoresis and immunochemical analysis, the two isolated com- 
plexes had identical subunit compositions, except that the MAC lacked the S-protein. 
The  sedimentation  coefficient and  molecular weight  of the  extracted  and  isolated 
MAC were, respectively, 33.5  S and  1.7  ×  106 daltons, compared to 23 S and  1.0  x 
106 dalton for SC5b-9. Because the molecular weight of the MAC is approximately 
two times greater than that of C5b-9 (800,000 daltons),  the MAC is considered the 
dimer of C5b-9. Under specified conditions, the 33.5 S dimer could be converted to 
the  23  S  monomer without  dissociation  of subunits.  The  MAC  had  the  electron 
microscopic appearance and dimensions that are characteristic for the complement 
produced  ultrastructural  membrane  lesions.  SC5b-9  had  a  different  ultrastructure 
that  is  dissimilar  to  the  morphology of the  lesions.  The  isolated  MAC  could  be 
reincorporated into phospholipid bilayers and assumed on the surface of the resultant 
lipid vesicles  the orientation and appearance of typical complement lesions. 
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